Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Michaela J. Haller"'
Autor:
Scott A. Tomlins, Celina G. Kleer, Catherine S. Grasso, Daniel R. Rhodes, Michael J. Quist, Chia-Jen Liu, Kate Rhodes, Paul D. Williams, Santhoshi Bandla, Jarred Bratley, Anmol M. Amin, Venkata Yadati, Michaela J. Haller, Seth Sadis, Andrew S. McDaniel, Daniel H. Hovelson, Andi K. Cani
Supplementary Figures S1-2, Tables S1-3. Figure S1. Comparison of the number of high confidence, non-synonymous somatic point mutations/indels and high level copy number alterations (CNAs) by tumor grade. Figure S2. Copy number plots of representativ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1686bc69095ac0a5fbc87d84c43228a
https://doi.org/10.1158/1541-7786.22514295.v1
https://doi.org/10.1158/1541-7786.22514295.v1
Autor:
Qiang Li, Rajesh C. Rao, Andi K. Cani, Samantha E. Rahrig, Moaaz Soliman, Daniel H. Hovelson, Jarred V. Bratley, César A. Briceño, Scott A. Tomlins, Michaela J. Haller, Andrew S. McDaniel, Chia Jen Liu
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Non-Hodgkin lymphoma of the orbit and ocular adnexa is the most common primary orbital malignancy. Treatments for low- (extra-nodal marginal zone and follicular lymphomas) and high-grade (diffuse large B-cell lymphoma) are associated with local and v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f4e3fd0ce386a5e813f90fa018c08a1
http://europepmc.org/articles/PMC4925176
http://europepmc.org/articles/PMC4925176
Autor:
Daniel Rhodes, Andi K. Cani, Daniel H. Hovelson, Kate Rhodes, Venkata Yadati, Michael J. Quist, Scott A. Tomlins, Michaela J. Haller, Santhoshi Bandla, Chia Jen Liu, Seth Sadis, Paul D. Williams, Anmol Amin, Andrew S. McDaniel, Celina G. Kleer, Jarred V. Bratley, Catherine S. Grasso
Phyllodes tumors are rare fibroepithelial tumors with variable clinical behavior accounting for a small subset of all breast neoplasms, yet little is known about the genetic alterations that drive tumor initiation and/or progression. Here, targeted n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ed4e458250012c3db0e240c0fbc9e96
https://europepmc.org/articles/PMC4936398/
https://europepmc.org/articles/PMC4936398/